Skip to main content
S 1844 118th Congress Senate Health Research and development User charges and fees Veterinary medicine and animal diseases

Animal Drug User Fee Amendments of 2023

Introduced: June 7, 2023 Introduced by: Baldwin, Tammy Democratic · Wisconsin See on congress.gov
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 26, 2023
Placed on Senate Legislative Calendar under General Orders. Calendar No. 174.
Jul 26, 2023
Committee on Health, Education, Labor, and Pensions. Reported by Senator Sanders with an amendment. Without written report.
Jun 15, 2023
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment favorably.
Jun 7, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jun 7, 2023
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Animal Drug and Animal Generic Drug User Fee Amendments of 2023

This bill reauthorizes the Food and Drug Administration (FDA) to collect fees for brand-name and generic animal drug applications through FY2028. It also makes related updates to fee calculations and FDA reporting requirements.

The bill also (1) provides for a specific fee for requests to establish generic investigational new animal drug files and requires other application fees to be adjusted accordingly; (2) authorizes the FDA to remove species from the definition of major species (currently horses, dogs, cats, cattle, pigs, chickens, and turkeys); (3) provides statutory authority for the FDA to report on its progress supporting antimicrobial stewardship in veterinary settings (i.e., supporting responsible use of antimicrobial drugs for animals to slow the development of drug-resistant bacteria); and (4) provides for the regulation of zootechnical animal food substances as food additives (zootechnical animal food substances are added to the food or drinking water of animals to affect the byproducts of the animal's digestion, reduce foodborne pathogens, or alter the animal's gastrointestinal biome).

Animal drugs are drugs that are intended for animals other than humans (e.g., pets and livestock). Animal drugs must be approved by the FDA before they may be offered on the commercial market. The FDA is authorized to collect fees for animal drug applications in order to support its regulatory activities; this authority currently expires at the end of FY2023.

What's happening now July 26, 2023

Placed on Senate Legislative Calendar under General Orders. Calendar No. 174.

 Related & companion bills 4
 Bill text 2 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 1844: Animal Drug and Animal Generic Drug User Fee Amendments of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-S-1844/
MLA
"S. 1844: Animal Drug and Animal Generic Drug User Fee Amendments of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-1844/.
Bluebook (legal)
S. 1844, 118th Cong. (2026), https://openamerica.io/bill/118-S-1844/.
Markdown link
[S. 1844: Animal Drug and Animal Generic Drug User Fee Amendments of 2023](https://openamerica.io/bill/118-S-1844/)
Report a problem